(+)-artemisinic acid decreases expression ISO RGD:69121 6480464 [artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA, artemisic acid results in decreased expression of CEBPA mRNA CTD PMID:23063590 (+)-artemisinic acid multiple interactions ISO RGD:69121 6480464 [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol CTD PMID:23063590 (+)-pilocarpine multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] CTD PMID:32494933 (-)-cotinine multiple interactions EXP 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein CTD PMID:29617909 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:10325 6480464 epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein] CTD PMID:20438794 (1->4)-beta-D-glucan multiple interactions ISO RGD:10325 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CEBPA mRNA CTD PMID:36331819 (S)-nicotine multiple interactions EXP 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein CTD PMID:29617909 (S)-nicotine affects expression EXP 6480464 Nicotine affects the expression of CEBPA mRNA CTD PMID:31972234 (S)-nicotine increases expression ISO RGD:10325 6480464 Nicotine results in increased expression of CEBPA mRNA CTD PMID:31622651 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,2-dimethylhydrazine multiple interactions ISO RGD:10325 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CEBPA mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:10325 6480464 1, 2-Dimethylhydrazine results in increased expression of CEBPA mRNA CTD PMID:22206623 1-nitropyrene multiple interactions ISO RGD:69121 6480464 [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA], CEBPA protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein] CTD PMID:29078374 1-nitropyrene decreases expression ISO RGD:69121 6480464 1-nitropyrene results in decreased expression of CEBPA mRNA CTD PMID:29078374 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:10325 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased expression of CEBPA mRNA CTD PMID:12021203 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CEBPA protein CTD PMID:12507762 17beta-estradiol affects expression ISO RGD:10325 6480464 Estradiol affects the expression of CEBPA mRNA CTD PMID:15598610 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CEBPA mRNA CTD PMID:32145629 , PMID:35192832 17beta-estradiol multiple interactions ISO RGD:69121 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CEBPA mRNA CTD PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CEBPA mRNA CTD PMID:26164745 17beta-estradiol decreases expression ISO RGD:69121 6480464 Estradiol results in decreased expression of CEBPA mRNA CTD PMID:20106945 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:69121 6480464 Dihydrotestosterone results in decreased expression of CEBPA protein CTD PMID:18801408 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:10325 6480464 Dihydrotestosterone results in decreased expression of CEBPA mRNA, Dihydrotestosterone results in decreased expression of CEBPA protein CTD PMID:12960001 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:10325 6480464 2 more ... CTD PMID:24559133 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10325 6480464 Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69121 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA CTD PMID:28011154 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69121 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10325 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]], Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter] CTD PMID:11133817 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10325 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA, Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein CTD PMID:12758056 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10325 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein] more ... CTD PMID:12758056 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:10325 6480464 2 more ... CTD PMID:30903904 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene results in decreased expression of CEBPA protein CTD PMID:20188851 , PMID:21785164 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:10325 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein more ... CTD PMID:22107987 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression ISO RGD:10325 6480464 glucosamine 6-phosphate results in decreased expression of CEBPA protein CTD PMID:19427183 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10325 6480464 tetrabromobisphenol A results in increased expression of CEBPA mRNA CTD PMID:25863188 , PMID:30496566 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:69121 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA more ... CTD PMID:33476690 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10325 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CEBPA mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine affects methylation ISO RGD:10325 6480464 N-Methyl-3, 4-methylenedioxyamphetamine affects the methylation of CEBPA promoter CTD PMID:26251327 3,5,6-trichloro-2-pyridinol multiple interactions ISO RGD:10325 6480464 3 more ... CTD PMID:32017950 3,5,6-trichloropyridine-2-one multiple interactions ISO RGD:10325 6480464 3 more ... CTD PMID:32017950 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10325 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... CTD PMID:11101056 more ... 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69121 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of CEBPA mRNA more ... CTD PMID:23152186 more ... 3-methyladenine multiple interactions ISO RGD:69121 6480464 [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] CTD PMID:29078374 3-methylcholanthrene multiple interactions ISO RGD:10325 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA CTD PMID:23519560 3-phenylprop-2-enal decreases expression ISO RGD:10325 6480464 cinnamaldehyde results in decreased expression of CEBPA mRNA CTD PMID:21401097 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of CEBPA mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:69121 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CEBPA mRNA CTD PMID:27003841 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69121 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CEBPA protein, [bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA CTD PMID:33865937 4,4'-sulfonyldiphenol increases expression ISO RGD:10325 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CEBPA mRNA CTD PMID:30951980 , PMID:30959087 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10325 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA, [bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of CEBPA protein CTD PMID:27273607 , PMID:32220626 4-hydroxynon-2-enal increases expression ISO RGD:10325 6480464 4-hydroxy-2-nonenal results in increased expression of CEBPA mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide decreases expression ISO RGD:10325 6480464 Fenretinide results in decreased expression of CEBPA mRNA CTD PMID:16467112 4-tert-Octylphenol decreases expression EXP 6480464 4-tert-octylphenol results in decreased expression of CEBPA mRNA CTD PMID:26164745 5-aza-2'-deoxycytidine decreases methylation ISO RGD:69121 6480464 Decitabine results in decreased methylation of CEBPA promoter CTD PMID:19194470 5-aza-2'-deoxycytidine affects methylation ISO RGD:69121 6480464 Decitabine affects the methylation of CEBPA promoter CTD PMID:17510391 5-azacytidine decreases methylation ISO RGD:69121 6480464 Azacitidine results in decreased methylation of CEBPA promoter CTD PMID:19194470 5-azacytidine increases expression ISO RGD:69121 6480464 Azacitidine results in increased expression of CEBPA mRNA CTD PMID:27590069 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CEBPA mRNA CTD PMID:22504374 9,10-epoxy-12-octadecenoic acid increases expression ISO RGD:10325 6480464 9, 10-epoxy-12-octadecenoic acid results in increased expression of CEBPA mRNA CTD PMID:12021203 acrylamide multiple interactions ISO RGD:10325 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA] more ... CTD PMID:30409764 aflatoxin B1 affects expression ISO RGD:69121 6480464 Aflatoxin B1 affects the expression of CEBPA protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:69121 6480464 Aflatoxin B1 results in decreased expression of CEBPA mRNA CTD PMID:27153756 , PMID:32234424 AICA ribonucleotide decreases expression ISO RGD:10325 6480464 AICA ribonucleotide results in decreased expression of CEBPA protein CTD PMID:27103584 AICA ribonucleotide multiple interactions ISO RGD:10325 6480464 AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] CTD PMID:27103584 alcohol decreases expression ISO RGD:69121 6480464 Alcohols results in decreased expression of CEBPA protein CTD PMID:24025710 aldehydo-D-glucosamine 6-phosphate decreases expression ISO RGD:10325 6480464 glucosamine 6-phosphate results in decreased expression of CEBPA protein CTD PMID:19427183 aldehydo-D-glucose multiple interactions ISO RGD:69121 6480464 CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 all-trans-retinoic acid multiple interactions ISO RGD:69121 6480464 PTK2 protein inhibits the reaction [Tretinoin promotes the reaction [CEBPA protein binds to RB1 protein]] more ... CTD PMID:16226872 more ... all-trans-retinoic acid increases activity ISO RGD:69121 6480464 Tretinoin results in increased activity of CEBPA protein CTD PMID:16226872 all-trans-retinoic acid multiple interactions ISO RGD:10325 6480464 Tretinoin inhibits the reaction [CEBPA protein binds to RETN promoter] CTD PMID:15047602 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CEBPA mRNA CTD PMID:16483693 andrographolide multiple interactions ISO RGD:10325 6480464 andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA], andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:27475717 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:69121 6480464 pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 antimonite multiple interactions ISO RGD:69121 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA CTD PMID:32076005 antimycin A increases expression ISO RGD:69121 6480464 Antimycin A results in increased expression of CEBPA mRNA CTD PMID:33512557 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CEBPA mRNA CTD PMID:11163329 arsane decreases expression ISO RGD:69121 6480464 Arsenic results in decreased expression of CEBPA mRNA, Arsenic results in decreased expression of CEBPA protein CTD PMID:23108036 arsane multiple interactions ISO RGD:69121 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA, Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] CTD PMID:23108036 , PMID:32525701 arsenic atom multiple interactions ISO RGD:69121 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA, Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] CTD PMID:23108036 , PMID:32525701 arsenic atom decreases expression ISO RGD:69121 6480464 Arsenic results in decreased expression of CEBPA mRNA, Arsenic results in decreased expression of CEBPA protein CTD PMID:23108036 arsenite(3-) increases expression ISO RGD:10325 6480464 arsenite results in increased expression of CEBPA mRNA CTD PMID:15868481 arsenite(3-) multiple interactions ISO RGD:69121 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CEBPA mRNA CTD PMID:32076005 arsenous acid decreases expression ISO RGD:10325 6480464 Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:15916724 arsenous acid decreases expression ISO RGD:69121 6480464 Arsenic Trioxide results in decreased expression of CEBPA mRNA, Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:19662097 , PMID:21257625 arsenous acid increases expression ISO RGD:69121 6480464 Arsenic Trioxide results in increased expression of CEBPA mRNA CTD PMID:20458559 avobenzone decreases expression ISO RGD:69121 6480464 avobenzone results in decreased expression of CEBPA mRNA CTD PMID:31016361 baicalein decreases expression ISO RGD:10325 6480464 baicalein results in decreased expression of CEBPA protein CTD PMID:24560969 benzamides increases expression ISO RGD:10325 6480464 Benzamides results in increased expression of CEBPA mRNA CTD PMID:28242381 benzo[a]pyrene decreases expression ISO RGD:10325 6480464 Benzo(a)pyrene results in decreased expression of CEBPA mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:69121 6480464 Benzo(a)pyrene results in increased methylation of CEBPA exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:69121 6480464 Benzo(a)pyrene results in decreased expression of CEBPA mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:10325 6480464 Benzo(a)pyrene results in increased expression of CEBPA mRNA CTD PMID:15034205 benzo[a]pyrene increases expression ISO RGD:69121 6480464 Benzo(a)pyrene results in increased expression of CEBPA mRNA CTD PMID:21714911 benzo[a]pyrene diol epoxide I increases expression ISO RGD:69121 6480464 7 more ... CTD PMID:19150397 benzofurans decreases expression ISO RGD:10325 6480464 Benzofurans results in decreased expression of CEBPA mRNA, Benzofurans results in decreased expression of CEBPA protein CTD PMID:20863820 Benzyl parahydroxybenzoate increases expression ISO RGD:10325 6480464 benzylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 , PMID:27659731 berberine multiple interactions ISO RGD:10325 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA] more ... CTD PMID:20564506 berberine decreases expression ISO RGD:69121 6480464 Berberine results in decreased expression of CEBPA mRNA CTD PMID:26478571 beta-carotene decreases expression ISO RGD:10325 6480464 beta Carotene results in decreased expression of CEBPA mRNA CTD PMID:21569430 beta-D-glucosamine 6-sulfate decreases expression ISO RGD:10325 6480464 glucosamine 6-O-sulfate results in decreased expression of CEBPA mRNA, glucosamine 6-O-sulfate results in decreased expression of CEBPA protein CTD PMID:19520133 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of CEBPA mRNA, beta-Naphthoflavone results in decreased expression of CEBPA protein CTD PMID:19389873 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10325 6480464 Diethylhexyl Phthalate results in decreased expression of CEBPA mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10325 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA CTD PMID:37021957 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69121 6480464 Diethylhexyl Phthalate results in increased expression of CEBPA mRNA CTD PMID:31163220 bismuth atom multiple interactions ISO RGD:69121 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA CTD PMID:34560244 bismuthane multiple interactions ISO RGD:69121 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA CTD PMID:34560244 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CEBPA mRNA CTD PMID:20019905 more ... bisphenol A increases methylation ISO RGD:69121 6480464 bisphenol A results in increased methylation of CEBPA gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:69121 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CEBPA gene more ... CTD PMID:31601247 more ... bisphenol A multiple interactions EXP 6480464 lithospermate B inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA] CTD PMID:34165232 bisphenol A decreases expression ISO RGD:69121 6480464 bisphenol A analog results in decreased expression of CEBPA mRNA, bisphenol A results in decreased expression of CEBPA mRNA CTD PMID:32387340 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CEBPA gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CEBPA mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:69121 6480464 bisphenol A results in increased expression of CEBPA mRNA, bisphenol A results in increased expression of CEBPA protein CTD PMID:24418828 more ... bisphenol A decreases expression ISO RGD:10325 6480464 bisphenol A results in decreased expression of CEBPA mRNA, bisphenol A results in decreased expression of CEBPA protein CTD PMID:26146954 , PMID:30133442 bisphenol A increases expression ISO RGD:10325 6480464 bisphenol A results in increased expression of CEBPA more ... CTD PMID:26942597 more ... bisphenol A multiple interactions ISO RGD:10325 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of CEBPA protein more ... CTD PMID:26820058 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:10325 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] CTD PMID:22956630 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [TRIB3 protein affects the expression of CEBPA protein] CTD PMID:21190014 Bisphenol B decreases expression ISO RGD:69121 6480464 bisphenol B results in decreased expression of CEBPA mRNA CTD PMID:32387340 bisphenol F increases expression ISO RGD:10325 6480464 bisphenol F results in increased expression of CEBPA mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:69121 6480464 [bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA, [bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein CTD PMID:33865937 boric acid multiple interactions ISO RGD:10325 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA] more ... CTD PMID:28285642 bortezomib multiple interactions ISO RGD:69121 6480464 Bortezomib inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] CTD PMID:19662097 Butylbenzyl phthalate multiple interactions ISO RGD:10325 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA mRNA more ... CTD PMID:26820058 more ... Butylparaben multiple interactions ISO RGD:10325 6480464 2 more ... CTD PMID:22956630 more ... Butylparaben increases expression ISO RGD:10325 6480464 butylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 more ... Butylparaben increases expression ISO RGD:69121 6480464 butylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CEBPA mRNA CTD PMID:19167457 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of CEBPA mRNA CTD PMID:17327700 cadmium atom multiple interactions ISO RGD:69121 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA CTD PMID:35301059 cadmium atom multiple interactions ISO RGD:10325 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA CTD PMID:29939372 cadmium atom decreases expression ISO RGD:10325 6480464 Cadmium results in decreased expression of CEBPA protein CTD PMID:21848503 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CEBPA mRNA CTD PMID:17327700 cadmium dichloride multiple interactions ISO RGD:69121 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:10325 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA more ... CTD PMID:23921151 , PMID:29939372 cadmium dichloride increases expression ISO RGD:69121 6480464 Cadmium Chloride results in increased expression of CEBPA mRNA CTD PMID:12160620 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of CEBPA mRNA CTD PMID:23727198 caffeine increases expression EXP 6480464 Caffeine results in increased expression of CEBPA mRNA CTD PMID:30423288 , PMID:30776459 caffeine affects expression EXP 6480464 Caffeine affects the expression of CEBPA mRNA CTD PMID:30528684 calcitriol decreases expression ISO RGD:10325 6480464 Calcitriol results in decreased expression of CEBPA mRNA CTD PMID:16368784 calcium dichloride increases activity ISO RGD:69121 6480464 Calcium Chloride results in increased activity of CEBPA protein CTD PMID:17214633 cannabidiolic acid increases expression ISO RGD:10325 6480464 cannabidiolic acid results in increased expression of CEBPA mRNA CTD PMID:30611848 cannabidiolic acid multiple interactions ISO RGD:10325 6480464 cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] CTD PMID:30611848 capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] CTD PMID:20359164 capsaicin decreases expression ISO RGD:10325 6480464 Capsaicin results in decreased expression of CEBPA protein CTD PMID:17295509 carbaryl decreases expression ISO RGD:69121 6480464 Carbaryl results in decreased expression of CEBPA mRNA CTD PMID:27829164 carbon nanotube decreases expression ISO RGD:10325 6480464 Nanotubes more ... CTD PMID:25620056 celastrol affects expression ISO RGD:10325 6480464 celastrol affects the expression of CEBPA mRNA, celastrol affects the expression of CEBPA protein CTD PMID:27085773 celecoxib multiple interactions EXP 6480464 Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] CTD PMID:19247274 cerulenin decreases expression ISO RGD:10325 6480464 Cerulenin results in decreased expression of CEBPA mRNA CTD PMID:15707987 ceruletide multiple interactions EXP 6480464 [Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPA protein more ... CTD PMID:26873426 ceruletide increases expression EXP 6480464 Ceruletide results in increased expression of CEBPA mRNA CTD PMID:26873426 CGP 52608 multiple interactions ISO RGD:69121 6480464 CGP 52608 promotes the reaction [RORA protein binds to CEBPA gene] CTD PMID:28238834 chlorpyrifos multiple interactions ISO RGD:10325 6480464 Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA], Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:32017950 chlorpyrifos increases expression ISO RGD:10325 6480464 Chlorpyrifos results in increased expression of CEBPA mRNA CTD PMID:37019170 cholesterol multiple interactions ISO RGD:69121 6480464 [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol CTD PMID:23063590 choline multiple interactions ISO RGD:10325 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... CTD PMID:20938992 , PMID:25712622 choline multiple interactions ISO RGD:69121 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA], [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA CTD PMID:25712622 cisplatin decreases expression ISO RGD:69121 6480464 Cisplatin results in decreased expression of CEBPA mRNA CTD PMID:27392435 clofazimine increases expression EXP 6480464 Clofazimine results in increased expression of CEBPA protein CTD PMID:31393584 Clofop multiple interactions ISO RGD:69121 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of CEBPA mRNA CTD PMID:16197558 clozapine multiple interactions ISO RGD:10325 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA], Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein] CTD PMID:20564506 clozapine increases expression ISO RGD:10325 6480464 Clozapine results in increased expression of CEBPA mRNA, Clozapine results in increased expression of CEBPA protein CTD PMID:20564506 cobalt dichloride decreases expression ISO RGD:10325 6480464 cobaltous chloride results in decreased expression of CEBPA mRNA CTD PMID:20594416 colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of CEBPA protein CTD PMID:21832167 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] CTD PMID:21832167 colforsin daropate hydrochloride multiple interactions ISO RGD:10325 6480464 Colforsin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA] CTD PMID:17407152 copper(II) sulfate decreases expression ISO RGD:69121 6480464 Copper Sulfate results in decreased expression of CEBPA mRNA CTD PMID:19549813 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CEBPA mRNA CTD PMID:30423288 cortisol multiple interactions ISO RGD:69121 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA more ... CTD PMID:30528684 more ... cortisol increases expression ISO RGD:69121 6480464 Hydrocortisone results in increased expression of CEBPA mRNA, Hydrocortisone results in increased expression of CEBPA protein CTD PMID:30528684 more ... cucurbitacin B decreases expression ISO RGD:10325 6480464 cucurbitacin B results in decreased expression of CEBPA mRNA CTD PMID:24316209 cucurbitacin B multiple interactions ISO RGD:10325 6480464 STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of CEBPA mRNA] CTD PMID:24316209 cucurbitacin I decreases expression ISO RGD:10325 6480464 cucurbitacin I results in decreased expression of CEBPA mRNA CTD PMID:24316209 curcumin multiple interactions ISO RGD:10325 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] more ... CTD PMID:19297423 , PMID:28595985 cyclosporin A decreases expression ISO RGD:69121 6480464 Cyclosporine results in decreased expression of CEBPA mRNA CTD PMID:20106945 more ... D-glucose multiple interactions ISO RGD:69121 6480464 CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 DDE decreases activity ISO RGD:69121 6480464 Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPA protein CTD PMID:27589886 DDT multiple interactions ISO RGD:10325 6480464 DDT results in increased activity of and results in increased localization of CEBPA protein CTD PMID:11911853 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CEBPA mRNA CTD PMID:23914054 deguelin decreases expression ISO RGD:69121 6480464 [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CEBPA protein CTD PMID:25242579 deoxynivalenol multiple interactions ISO RGD:69121 6480464 [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA CTD PMID:28865950 deoxynivalenol decreases expression ISO RGD:69121 6480464 deoxynivalenol results in decreased expression of CEBPA mRNA CTD PMID:28935499 dexamethasone multiple interactions ISO RGD:10325 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... CTD PMID:11101056 more ... dexamethasone multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] CTD PMID:32494933 dexamethasone increases expression ISO RGD:10325 6480464 Dexamethasone results in increased expression of CEBPA mRNA CTD PMID:22956630 , PMID:25068083 dexamethasone increases expression ISO RGD:69121 6480464 Dexamethasone results in increased expression of CEBPA mRNA CTD PMID:24418828 , PMID:27003841 dexamethasone multiple interactions ISO RGD:69121 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA more ... CTD PMID:23152186 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CEBPA mRNA, Dexamethasone results in increased expression of CEBPA protein CTD PMID:12837037 more ... diallyl trisulfide decreases expression ISO RGD:10325 6480464 diallyl trisulfide results in decreased expression of CEBPA mRNA, diallyl trisulfide results in decreased expression of CEBPA protein CTD PMID:22137902 diallyl trisulfide multiple interactions ISO RGD:10325 6480464 [diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN more ... CTD PMID:22137902 diarsenic trioxide decreases expression ISO RGD:10325 6480464 Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:15916724 diarsenic trioxide decreases expression ISO RGD:69121 6480464 Arsenic Trioxide results in decreased expression of CEBPA mRNA, Arsenic Trioxide results in decreased expression of CEBPA protein CTD PMID:19662097 , PMID:21257625 diarsenic trioxide increases expression ISO RGD:69121 6480464 Arsenic Trioxide results in increased expression of CEBPA mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:10325 6480464 Dibutyl Phthalate results in decreased expression of CEBPA mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:10325 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA CTD PMID:37021957 dibutylstannane increases expression ISO RGD:69121 6480464 di-n-butyltin results in increased expression of CEBPA mRNA CTD PMID:29787037 dibutylstannane multiple interactions ISO RGD:69121 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of CEBPA mRNA] CTD PMID:29787037 diethyl phthalate multiple interactions ISO RGD:10325 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA CTD PMID:37021957 diethylstilbestrol increases expression ISO RGD:10325 6480464 Diethylstilbestrol results in increased expression of CEBPA mRNA, Diethylstilbestrol results in increased expression of CEBPA protein CTD PMID:22710028 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CEBPA mRNA CTD PMID:37077353 diethylstilbestrol multiple interactions ISO RGD:10325 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of CEBPA protein] CTD PMID:22710028 diisobutyl phthalate multiple interactions ISO RGD:10325 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA CTD PMID:37021957 diisononyl phthalate multiple interactions ISO RGD:10325 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA CTD PMID:37021957 dioxygen decreases expression ISO RGD:10325 6480464 Oxygen deficiency results in decreased expression of CEBPA mRNA CTD PMID:20594416 dioxygen multiple interactions ISO RGD:10325 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPA mRNA CTD PMID:30529165 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:69121 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA CTD PMID:32076005 diquat increases expression ISO RGD:10325 6480464 Diquat results in increased expression of CEBPA mRNA CTD PMID:36851058 doxorubicin decreases expression ISO RGD:69121 6480464 Doxorubicin results in decreased expression of CEBPA protein CTD PMID:19662097 duvoglustat multiple interactions ISO RGD:10325 6480464 1-Deoxynojirimycin inhibits the reaction [Dietary Fats results in increased expression of CEBPA mRNA] CTD PMID:25445511 efavirenz decreases expression ISO RGD:69121 6480464 efavirenz results in decreased expression of CEBPA mRNA CTD PMID:21619898 elemental selenium increases expression ISO RGD:10325 6480464 Selenium results in increased expression of CEBPA mRNA CTD PMID:28810182 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CEBPA mRNA CTD PMID:29391264 endrin decreases activity ISO RGD:10325 6480464 Endrin results in decreased activity of CEBPA protein CTD PMID:10385688 endrin increases expression ISO RGD:10325 6480464 Endrin results in increased expression of CEBPA mRNA CTD PMID:34801515 endrin decreases expression ISO RGD:10325 6480464 Endrin results in decreased expression of CEBPA protein CTD PMID:10385688 enzalutamide affects expression ISO RGD:69121 6480464 enzalutamide affects the expression of CEBPA mRNA CTD PMID:30940724 epoxiconazole increases expression ISO RGD:10325 6480464 epoxiconazole results in increased expression of CEBPA mRNA CTD PMID:35436446 epoxomicin multiple interactions ISO RGD:69121 6480464 epoxomicin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] CTD PMID:19662097 ethanol decreases activity ISO RGD:10325 6480464 Ethanol results in decreased activity of CEBPA protein CTD PMID:16737972 ethanol increases expression ISO RGD:69121 6480464 Ethanol results in increased expression of CEBPA mRNA CTD PMID:35713687 ethanol multiple interactions ISO RGD:69121 6480464 HECTD4 protein promotes the reaction [Ethanol results in increased expression of CEBPA mRNA] CTD PMID:35713687 ethanol affects expression ISO RGD:10325 6480464 Ethanol affects the expression of CEBPA mRNA CTD PMID:30319688 ethanol affects expression EXP 6480464 Ethanol affects the expression of CEBPA mRNA CTD PMID:31039417 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CEBPA mRNA CTD PMID:26188107 more ... ethanol decreases expression ISO RGD:10325 6480464 Ethanol results in decreased expression of CEBPA protein CTD PMID:16737972 ethanol multiple interactions ISO RGD:10325 6480464 Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein], Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] CTD PMID:16737972 ethanol decreases expression ISO RGD:69121 6480464 Ethanol results in decreased expression of CEBPA protein CTD PMID:16737972 ethylparaben increases expression ISO RGD:10325 6480464 ethyl-p-hydroxybenzoate results in increased expression of CEBPA mRNA CTD PMID:22956630 etoposide increases degradation ISO RGD:69121 6480464 Etoposide results in increased degradation of CEBPA protein CTD PMID:19662097 etoposide decreases expression ISO RGD:69121 6480464 Etoposide results in decreased expression of CEBPA mRNA, Etoposide results in decreased expression of CEBPA protein CTD PMID:19662097 fenthion increases expression ISO RGD:10325 6480464 Fenthion results in increased expression of CEBPA mRNA CTD PMID:34813904 fipronil multiple interactions ISO RGD:10325 6480464 AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] CTD PMID:27103584 fipronil increases expression ISO RGD:10325 6480464 fipronil results in increased expression of CEBPA mRNA, fipronil results in increased expression of CEBPA protein CTD PMID:27103584 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CEBPA mRNA CTD PMID:23238999 folic acid multiple interactions ISO RGD:10325 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... CTD PMID:20938992 , PMID:22206623 fulvestrant multiple interactions ISO RGD:69121 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CEBPA gene CTD PMID:31601247 genistein decreases expression ISO RGD:10325 6480464 Genistein results in decreased expression of CEBPA mRNA CTD PMID:21048042 genistein increases expression EXP 6480464 Genistein results in increased expression of CEBPA mRNA CTD PMID:24361872 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CEBPA mRNA CTD PMID:33387578 Geraniin multiple interactions ISO RGD:10325 6480464 STO 609 inhibits the reaction [Geraniin results in increased expression of CEBPA protein] CTD PMID:36706894 Geraniin increases expression ISO RGD:10325 6480464 Geraniin results in increased expression of CEBPA protein CTD PMID:36706894 gingerol decreases expression ISO RGD:10325 6480464 gingerol results in decreased expression of CEBPA mRNA, gingerol results in decreased expression of CEBPA protein CTD PMID:26498061 gingerol multiple interactions ISO RGD:10325 6480464 GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA], GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein] CTD PMID:26498061 glucose multiple interactions ISO RGD:69121 6480464 CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 glycerol 2-phosphate multiple interactions ISO RGD:10325 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein CTD PMID:14505802 glycerol 2-phosphate multiple interactions ISO RGD:69121 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA CTD PMID:25932594 glycyrrhizinic acid multiple interactions ISO RGD:10325 6480464 Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA] CTD PMID:34302803 GW 501516 multiple interactions ISO RGD:69121 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA CTD PMID:16197558 hemin multiple interactions ISO RGD:10325 6480464 HAMP mRNA promotes the reaction [Hemin results in increased expression of CEBPA mRNA] CTD PMID:29749404 hemin increases expression ISO RGD:10325 6480464 Hemin results in increased expression of CEBPA mRNA CTD PMID:29749404 herbimycin multiple interactions EXP 6480464 herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] CTD PMID:11133817 hesperetin decreases expression ISO RGD:69121 6480464 hesperetin results in decreased expression of CEBPA protein CTD PMID:25345581 hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA more ... CTD PMID:26873426 hexadecanoic acid multiple interactions ISO RGD:10325 6480464 [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA more ... CTD PMID:34968464 hispidulin multiple interactions ISO RGD:10325 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA] CTD PMID:30055130 hydrazines decreases expression ISO RGD:10325 6480464 Hydrazines results in decreased expression of CEBPA mRNA CTD PMID:21647536 hydrogen peroxide affects expression ISO RGD:69121 6480464 Hydrogen Peroxide affects the expression of CEBPA mRNA CTD PMID:23410634 hydroxytyrosol decreases expression ISO RGD:10325 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of CEBPA mRNA CTD PMID:21569430 indirubin multiple interactions ISO RGD:10325 6480464 [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPA protein], [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPA protein] CTD PMID:18344322 indometacin multiple interactions ISO RGD:10325 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA more ... CTD PMID:22107987 more ... indometacin multiple interactions ISO RGD:69121 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CEBPA mRNA CTD PMID:28628672 , PMID:34560244 isoliquiritigenin multiple interactions ISO RGD:10325 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] CTD PMID:27117918 isoniazide decreases expression ISO RGD:10325 6480464 Isoniazid results in decreased expression of CEBPA mRNA, Isoniazid results in decreased expression of CEBPA protein CTD PMID:24128855 ivermectin affects expression ISO RGD:10325 6480464 Ivermectin affects the expression of CEBPA mRNA CTD PMID:31199990 ivermectin multiple interactions ISO RGD:10325 6480464 Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein], Rosiglitazone affects the reaction [Ivermectin affects the expression of CEBPA mRNA] CTD PMID:31199990 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CEBPA mRNA CTD PMID:37077353 L-ascorbic acid multiple interactions ISO RGD:10325 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein CTD PMID:14505802 L-ascorbic acid multiple interactions ISO RGD:69121 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA CTD PMID:25932594 L-methionine multiple interactions ISO RGD:10325 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... CTD PMID:20938992 , PMID:25712622 L-methionine multiple interactions ISO RGD:69121 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA], [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA CTD PMID:25712622 lead diacetate increases expression ISO RGD:10325 6480464 lead acetate results in increased expression of CEBPA mRNA CTD PMID:20542052 lead diacetate increases methylation EXP 6480464 lead acetate results in increased methylation of CEBPA gene CTD PMID:29571894 lead diacetate decreases expression ISO RGD:10325 6480464 lead acetate results in decreased expression of CEBPA mRNA CTD PMID:21829687 lead(0) increases expression ISO RGD:10325 6480464 Lead results in increased expression of CEBPA CTD PMID:23086611 lipopolysaccharide multiple interactions ISO RGD:10325 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein more ... CTD PMID:22107987 lipopolysaccharide decreases expression ISO RGD:69121 6480464 Lipopolysaccharides results in decreased expression of CEBPA mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:69121 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEBPA mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:10325 6480464 Lipopolysaccharides results in decreased expression of CEBPA mRNA CTD PMID:26582142 lithium chloride multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] CTD PMID:32494933 LY294002 multiple interactions ISO RGD:69121 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA] CTD PMID:25712622 menadione affects expression ISO RGD:69121 6480464 Vitamin K 3 affects the expression of CEBPA mRNA CTD PMID:20044591 , PMID:23410634 mercury dichloride decreases expression ISO RGD:10325 6480464 Mercuric Chloride results in decreased expression of CEBPA mRNA CTD PMID:11267658 mercury dichloride multiple interactions ISO RGD:10325 6480464 Mercuric Chloride results in decreased expression of and results in decreased activity of CEBPA protein CTD PMID:11267658 metformin decreases expression EXP 6480464 Metformin results in decreased expression of CEBPA mRNA CTD PMID:19022234 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CEBPA mRNA CTD PMID:22504374 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of CEBPA mRNA CTD PMID:23303685 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of CEBPA gene CTD PMID:35440735 methylparaben increases expression ISO RGD:10325 6480464 methylparaben results in increased expression of CEBPA mRNA CTD PMID:28527915 mifepristone multiple interactions ISO RGD:10325 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA], Mifepristone inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] CTD PMID:22956630 , PMID:27145005 mifepristone multiple interactions ISO RGD:69121 6480464 Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of CEBPA mRNA] CTD PMID:30528684 MK-2206 multiple interactions ISO RGD:69121 6480464 MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of CEBPA protein] CTD PMID:34398343 MK-2206 decreases expression ISO RGD:69121 6480464 MK 2206 results in decreased expression of CEBPA protein CTD PMID:34398343 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:10325 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein CTD PMID:21832167 mono(2-ethylhexyl) phthalate increases expression ISO RGD:10325 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CEBPA mRNA CTD PMID:25543134 , PMID:27384973 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein CTD PMID:21832167 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] CTD PMID:21832167 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:10325 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA] CTD PMID:17407152 N-acetyl-L-cysteine multiple interactions ISO RGD:10325 6480464 Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] CTD PMID:27117918 N-acetyl-L-cysteine multiple interactions ISO RGD:69121 6480464 Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CEBPA protein] CTD PMID:35622622 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases ubiquitination ISO RGD:69121 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of CEBPA protein CTD PMID:19662097 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:69121 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] CTD PMID:19662097 N-nitrosodiethylamine decreases expression ISO RGD:69121 6480464 Diethylnitrosamine results in decreased expression of CEBPA mRNA CTD PMID:21527772 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CEBPA mRNA CTD PMID:19638242 N-Nitrosopyrrolidine decreases expression ISO RGD:69121 6480464 N-Nitrosopyrrolidine results in decreased expression of CEBPA mRNA CTD PMID:32234424 nevirapine increases expression ISO RGD:69121 6480464 Nevirapine results in increased expression of CEBPA mRNA CTD PMID:21619898 nicotine multiple interactions EXP 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein CTD PMID:29617909 nicotine affects expression EXP 6480464 Nicotine affects the expression of CEBPA mRNA CTD PMID:31972234 nicotine increases expression ISO RGD:10325 6480464 Nicotine results in increased expression of CEBPA mRNA CTD PMID:31622651 nicotinic acid increases expression ISO RGD:69121 6480464 Niacin results in increased expression of CEBPA mRNA CTD PMID:19131065 nimesulide multiple interactions ISO RGD:10325 6480464 nimesulide promotes the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein] CTD PMID:22107987 nimesulide multiple interactions EXP 6480464 nimesulide inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] CTD PMID:19247274 ochratoxin A decreases expression ISO RGD:69121 6480464 ochratoxin A results in decreased expression of CEBPA CTD PMID:20590410 orlistat multiple interactions ISO RGD:69121 6480464 Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein] CTD PMID:33476690 osthole increases expression ISO RGD:10325 6480464 osthol results in increased expression of CEBPA mRNA CTD PMID:19682441 p-tert-Amylphenol decreases expression EXP 6480464 4-tert-octylphenol results in decreased expression of CEBPA mRNA CTD PMID:26164745 paracetamol decreases expression ISO RGD:10325 6480464 Acetaminophen results in decreased expression of CEBPA mRNA CTD PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CEBPA mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:10325 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CEBPA mRNA] CTD PMID:29246445 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CEBPA mRNA CTD PMID:32680482 perfluorobutanesulfonic acid increases expression ISO RGD:10325 6480464 perfluorobutanesulfonic acid results in increased expression of CEBPA mRNA, perfluorobutanesulfonic acid results in increased expression of CEBPA protein CTD PMID:30031040 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10325 6480464 perfluorooctane sulfonic acid results in increased expression of CEBPA mRNA CTD PMID:26548598 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10325 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CEBPA mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid affects expression ISO RGD:69121 6480464 perfluorooctane sulfonic acid affects the expression of CEBPA mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid increases expression ISO RGD:69121 6480464 perfluorooctane sulfonic acid results in increased expression of CEBPA mRNA CTD PMID:26548598 perfluorooctanoic acid increases activity ISO RGD:69121 6480464 perfluorooctanoic acid results in increased activity of CEBPA protein CTD PMID:27589886 perfluorooctanoic acid multiple interactions ISO RGD:10325 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA], [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA CTD PMID:29094436 permethrin increases expression ISO RGD:10325 6480464 Permethrin results in increased expression of CEBPA mRNA CTD PMID:24911977 Phenylamil increases expression ISO RGD:10325 6480464 phenylamil results in increased expression of CEBPA mRNA CTD PMID:20519739 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of CEBPA mRNA CTD PMID:19443575 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10325 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA CTD PMID:23519560 pioglitazone increases expression ISO RGD:10325 6480464 pioglitazone results in increased expression of CEBPA mRNA CTD PMID:28242381 pirinixic acid multiple interactions ISO RGD:10325 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of CEBPA mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:10325 6480464 pirinixic acid results in decreased expression of CEBPA mRNA CTD PMID:18445702 more ... pirinixic acid multiple interactions ISO RGD:69121 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEBPA mRNA CTD PMID:19710929 platycodin D multiple interactions ISO RGD:10325 6480464 CTNNB1 affects the reaction [platycodin D results in decreased expression of CEBPA protein] CTD PMID:21798269 platycodin D decreases expression ISO RGD:69121 6480464 platycodin D results in decreased expression of CEBPA protein CTD PMID:30599906 platycodin D decreases expression ISO RGD:10325 6480464 platycodin D results in decreased expression of CEBPA mRNA, platycodin D results in decreased expression of CEBPA protein CTD PMID:21798269 more ... pomalidomide increases expression ISO RGD:69121 6480464 pomalidomide results in increased expression of CEBPA mRNA CTD PMID:15292067 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10325 6480464 Pregnenolone Carbonitrile results in decreased expression of CEBPA mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:10325 6480464 propiconazole results in decreased expression of CEBPA mRNA CTD PMID:21278054 propylparaben increases expression ISO RGD:10325 6480464 propylparaben results in increased expression of CEBPA mRNA CTD PMID:22956630 prostaglandin E2 multiple interactions ISO RGD:10325 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein]] CTD PMID:25432964 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPA protein] more ... CTD PMID:26873426 quercetin multiple interactions ISO RGD:10325 6480464 Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein] more ... CTD PMID:18586010 more ... quercetin decreases expression ISO RGD:69121 6480464 Quercetin results in decreased expression of CEBPA mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:10325 6480464 IWR-1 compound inhibits the reaction [Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]], Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:31470850 raloxifene decreases expression ISO RGD:69121 6480464 Raloxifene Hydrochloride results in decreased expression of CEBPA mRNA CTD PMID:15849065 reactive oxygen species decreases expression ISO RGD:69121 6480464 Reactive Oxygen Species results in decreased expression of CEBPA mRNA CTD PMID:25800948 resveratrol decreases expression ISO RGD:10325 6480464 resveratrol metabolite results in decreased expression of CEBPA mRNA more ... CTD PMID:22935344 more ... rifampicin multiple interactions ISO RGD:10325 6480464 [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPA mRNA more ... CTD PMID:33412187 rimonabant multiple interactions ISO RGD:10325 6480464 Rimonabant inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] CTD PMID:27659731 risperidone multiple interactions ISO RGD:10325 6480464 Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA mRNA], Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA protein] CTD PMID:20564506 risperidone increases expression ISO RGD:10325 6480464 Risperidone results in increased expression of CEBPA mRNA, Risperidone results in increased expression of CEBPA protein CTD PMID:20564506 ritonavir multiple interactions ISO RGD:10325 6480464 Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein] CTD PMID:11101056 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CEBPA mRNA, Rotenone results in decreased expression of CEBPA protein CTD PMID:19693701 rottlerin multiple interactions ISO RGD:69121 6480464 rottlerin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein], rottlerin inhibits the reaction [NSC606985 results in increased ubiquitination of CEBPA protein] CTD PMID:19662097 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:69121 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEBPA mRNA CTD PMID:35811015 SB 203580 multiple interactions ISO RGD:69121 6480464 SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 selenium atom increases expression ISO RGD:10325 6480464 Selenium results in increased expression of CEBPA mRNA CTD PMID:28810182 sildenafil citrate increases expression ISO RGD:10325 6480464 Sildenafil Citrate results in increased expression of CEBPA mRNA, Sildenafil Citrate results in increased expression of CEBPA protein CTD PMID:20471953 silibinin multiple interactions ISO RGD:10325 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] CTD PMID:25559859 silicon dioxide decreases expression ISO RGD:69121 6480464 Silicon Dioxide analog results in decreased expression of CEBPA mRNA, Silicon Dioxide results in decreased expression of CEBPA mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression ISO RGD:69121 6480464 Silicon Dioxide analog results in increased expression of CEBPA mRNA CTD PMID:23806026 silver atom decreases expression ISO RGD:69121 6480464 Silver results in decreased expression of CEBPA mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:69121 6480464 Silver results in decreased expression of CEBPA mRNA CTD PMID:26014281 sincalide multiple interactions EXP 6480464 [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA more ... CTD PMID:26873426 sirolimus decreases expression ISO RGD:10325 6480464 Sirolimus results in decreased expression of CEBPA mRNA CTD PMID:15358118 sodium arsenate multiple interactions ISO RGD:69121 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA CTD PMID:32525701 sodium arsenite multiple interactions ISO RGD:69121 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CEBPA mRNA, sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA] CTD PMID:23152186 , PMID:32076005 sodium arsenite decreases expression ISO RGD:69121 6480464 sodium arsenite results in decreased expression of CEBPA mRNA CTD PMID:29301061 , PMID:32844245 sodium arsenite decreases expression ISO RGD:10325 6480464 sodium arsenite results in decreased expression of CEBPA mRNA CTD PMID:19822182 more ... sodium arsenite multiple interactions ISO RGD:10325 6480464 [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA more ... CTD PMID:11812925 , PMID:34968464 sodium chloride increases expression ISO RGD:69121 6480464 Sodium Chloride results in increased expression of CEBPA mRNA CTD PMID:23634900 sodium dichromate increases expression ISO RGD:10325 6480464 sodium bichromate results in increased expression of CEBPA mRNA CTD PMID:31558096 stavudine decreases expression ISO RGD:10325 6480464 Stavudine results in decreased expression of CEBPA protein CTD PMID:15722030 sunitinib increases expression ISO RGD:69121 6480464 Sunitinib results in increased expression of CEBPA mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:10325 6480464 Tacrolimus results in increased expression of CEBPA mRNA CTD PMID:29362864 tamoxifen decreases expression ISO RGD:10325 6480464 Tamoxifen results in decreased expression of CEBPA mRNA, Tamoxifen results in decreased expression of CEBPA protein CTD PMID:25123088 Tanshinone I multiple interactions ISO RGD:10325 6480464 [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPA protein], [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPA protein] CTD PMID:18344322 Tanshinone I increases expression ISO RGD:10325 6480464 tanshinone results in increased expression of CEBPA protein CTD PMID:18344322 taurine multiple interactions ISO RGD:69121 6480464 [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] CTD PMID:29078374 tert-butyl hydroperoxide affects expression ISO RGD:69121 6480464 tert-Butylhydroperoxide affects the expression of CEBPA mRNA CTD PMID:23410634 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CEBPA mRNA CTD PMID:21270424 testosterone decreases expression ISO RGD:10325 6480464 Testosterone results in decreased expression of CEBPA mRNA, Testosterone results in decreased expression of CEBPA protein CTD PMID:12960001 tetrachloromethane multiple interactions ISO RGD:10325 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein]] more ... CTD PMID:20438794 , PMID:25432964 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CEBPA mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:10325 6480464 Carbon Tetrachloride results in decreased expression of CEBPA mRNA, Carbon Tetrachloride results in decreased expression of CEBPA protein CTD PMID:17484886 more ... thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CEBPA mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:10325 6480464 titanium dioxide results in increased expression of CEBPA mRNA CTD PMID:23409001 titanium dioxide decreases expression ISO RGD:69121 6480464 titanium dioxide results in decreased expression of CEBPA mRNA CTD PMID:34973136 tolylfluanid increases expression ISO RGD:10325 6480464 N-dichlorofluoromethylthio-N', N'-dimethyl-N-p-tolylsulfamide results in increased expression of CEBPA mRNA CTD PMID:34801515 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of CEBPA mRNA CTD PMID:16979414 tributylstannane increases expression ISO RGD:10325 6480464 tributyltin results in increased expression of CEBPA mRNA CTD PMID:25932594 , PMID:29787037 tributylstannane multiple interactions ISO RGD:69121 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of CEBPA mRNA] CTD PMID:29787037 tributylstannane multiple interactions ISO RGD:10325 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of CEBPA mRNA] CTD PMID:29787037 tributylstannane increases expression ISO RGD:69121 6480464 tributyltin results in increased expression of CEBPA mRNA CTD PMID:28011154 , PMID:29787037 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CEBPA mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:10325 6480464 Triclosan results in decreased expression of CEBPA mRNA CTD PMID:15707987 triphenyl phosphate increases expression ISO RGD:69121 6480464 triphenyl phosphate results in increased expression of CEBPA mRNA CTD PMID:28934090 triphenyl phosphate multiple interactions ISO RGD:69121 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of CEBPA mRNA, [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of CEBPA mRNA CTD PMID:28437481 triphenyl phosphate increases expression ISO RGD:10325 6480464 triphenyl phosphate results in increased expression of CEBPA mRNA CTD PMID:28163246 triptonide increases expression ISO RGD:10325 6480464 triptonide results in increased expression of CEBPA mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:69121 6480464 troglitazone results in increased expression of CEBPA mRNA CTD PMID:19022234 troglitazone multiple interactions ISO RGD:10325 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... CTD PMID:26117538 troglitazone increases expression ISO RGD:10325 6480464 troglitazone results in increased expression of CEBPA mRNA CTD PMID:12732648 more ... troglitazone multiple interactions ISO RGD:69121 6480464 [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of CEBPA mRNA, Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]] CTD PMID:27003841 , PMID:7956951 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CEBPA mRNA CTD PMID:19022234 trovafloxacin multiple interactions ISO RGD:10325 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CEBPA mRNA CTD PMID:18930950 urethane decreases expression ISO RGD:69121 6480464 Urethane results in decreased expression of CEBPA mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of CEBPA mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:69121 6480464 Valproic Acid results in decreased expression of CEBPA mRNA CTD PMID:29154799 , PMID:29501571 valproic acid decreases methylation ISO RGD:69121 6480464 Valproic Acid results in decreased methylation of CEBPA gene CTD PMID:29501571 valproic acid increases methylation ISO RGD:69121 6480464 Valproic Acid results in increased methylation of CEBPA gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:69121 6480464 CEBPA protein affects the reaction [Valproic Acid results in decreased expression of CALR mRNA] more ... CTD PMID:32623605 valproic acid increases expression ISO RGD:69121 6480464 Valproic Acid results in increased expression of CEBPA mRNA CTD PMID:19101580 valsartan decreases expression ISO RGD:69121 6480464 Valsartan results in decreased expression of CEBPA mRNA CTD PMID:22768174 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CEBPA mRNA CTD PMID:23034163 vitamin D multiple interactions ISO RGD:69121 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of CEBPA mRNA CTD PMID:33836827 vitamin E multiple interactions ISO RGD:10325 6480464 Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein], Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] CTD PMID:16737972 zearalenone affects expression ISO RGD:69121 6480464 Zearalenone affects the expression of CEBPA mRNA CTD PMID:28865950 zearalenone multiple interactions ISO RGD:69121 6480464 [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA CTD PMID:28865950 zidovudine decreases expression ISO RGD:10325 6480464 Zidovudine results in decreased expression of CEBPA protein CTD PMID:15722030 zinc atom multiple interactions ISO RGD:69121 6480464 CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA], CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] CTD PMID:15389791 , PMID:17363595 zinc atom increases response to substance ISO RGD:69121 6480464 CEBPA protein results in increased susceptibility to Zinc CTD PMID:15389791 zinc(0) multiple interactions ISO RGD:69121 6480464 CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA], CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] CTD PMID:15389791 , PMID:17363595 zinc(0) increases response to substance ISO RGD:69121 6480464 CEBPA protein results in increased susceptibility to Zinc CTD PMID:15389791 zoledronic acid increases expression ISO RGD:69121 6480464 zoledronic acid results in increased expression of CEBPA mRNA CTD PMID:20977926
